SEC Form 4 · accession 0001513162-18-000267
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Officer — Chief Executive Officer · Director
Period of report
Oct 25, 2018
Accepted (ET)
Oct 25, 2018 · 12:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 25, 2018 | P | 11,000 | $3.90 | A | 150,000 | D |
Table II — derivative securities
No Table II lines on this filing.